Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Breast Cancer Research

Figure 1

From: A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

Figure 1

Prognostic performance of the combined 14-gene HRneg/Tneg index in training and validation cohorts. Kaplan-Meier plots of distant metastatic events dichotomized at the upper third quartile by high (red) or low (green) scores of (a) combined 14-gene HRneg/Tneg index in the full HRneg training cohort (n = 199), (b) combined 14-gene HRneg/Tneg index in the Tneg subset of the training cohort (n = 154), and (c) combined 14-gene HRneg/Tneg index in the full HRneg validation cohort (n = 75). Significant differences in survival between groups were determined by log-rank analysis. DMFS, distant metastasis-free survival; HRneg, hormone receptor-negative; Tneg, triple-negative.

Back to article page